Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yousaf, Raja"'
Autor:
Azizul Hasan Aamir, Umar Yousaf Raja, Faisal Masood Qureshi, Ali Asghar, Saeed Ahmed Mahar, Ibrar Ahmed, Tahir Ghaffar, Jamal Zafar, Mohammad Imtiaz Hasan, Amna Riaz, Syed Abbas Raza, Irshad Ahmed Khosa, Jahanzeb Khan, Jaffer Bin Baqar
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Sodium-Glucose-Co-Transporter 2 (SGLT2) inhibitor (Empagliflozin) is an effective drug in controlling blood glucose through predominantly glycosuria. Glycosuria increases the risk of genitourinary infections in diabetes. This stud
Externí odkaz:
https://doaj.org/article/b9a375ce0eb24e1ca41f95c188d169b4
Autor:
Ibrar Ahmed, Umar Yousaf Raja, Muhammad Umar Wahab, Tejhmal Rehman, Osama Ishtiaq, A. H. Aamir, Tahir Ghaffar, Abbas Raza, Suresh Kumar, Akhtar Sherin, Faisal Masood, Fawad Ahmad Randhawa, Ali Asghar, Sehrish Khan
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Management of diabetes during fasting is a clinical challenge. Sodium glucose co-transporter -2 inhibitors (SGLT2i) are considered safe with a low risk of hypoglycemia. However, studies on SGLT2i are scarce. This study was designe
Externí odkaz:
https://doaj.org/article/3ba4973b5ac44d02b29ecea742043d9b
Publikováno v:
Frontiers in Heat & Mass Transfer; 2024, Vol. 22 Issue 4, p1261-1276, 16p
Autor:
Umar Yousaf Raja, Ponnusamy Saravanan
Publikováno v:
Journal of the Pakistan Medical Association, Vol 71, Iss 9 (2021)
Dapagliflozin is the first novel SGLT2 inhibitor for the treatment of Type 2 diabetes. The aim of this study was to evaluate its effectiveness and safety in a real-life clinical setting. We analyze data from four hospitals on patients initiated on da
Externí odkaz:
https://doaj.org/article/5da04ee516504bb280b0ab0b22de6057
Autor:
Ponnusamy Saravanan, Umar Yousaf Raja
Publikováno v:
Journal of the Pakistan Medical Association. 71:2214-2217
Dapagliflozin is the first novel SGLT2 inhibitor for the treatment of Type 2 diabetes. The aim of this study was to evaluate its effectiveness and safety in a real-life clinical setting. We analyze data from four hospitals on patients initiated on da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7a1ce4dfa4826910d46b994f6290a9b
https://doi.org/10.47391/jpma.01-117
https://doi.org/10.47391/jpma.01-117
Publikováno v:
JPMA. The Journal of the Pakistan Medical Association. 71(9)
Dapagliflozin is the first novel sodium glucose co transporter 2 inhibitor for the treatment of Type 2 diabetes. The aim of this audit was to evaluate its effectiveness and safety in a real-life clinical setting.We analyze data from four UK district
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d2312a976bc3ba6e573c113702f9d0e5
https://pubmed.ncbi.nlm.nih.gov/34580517
https://pubmed.ncbi.nlm.nih.gov/34580517
Publikováno v:
JPMA. The Journal of the Pakistan Medical Association. 71(9)
Medication is essential for diabetes care, and this is reflected in the Essential Medicines lists prepared by the World Health Organization and various countries. The need for essential diagnostics, and essential devices, however, has not been addres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f08587b5248d1f765661542127e20888
https://pubmed.ncbi.nlm.nih.gov/34580533
https://pubmed.ncbi.nlm.nih.gov/34580533
Autor:
Matiullah, Kamin, Sajjad Ali, Khan, Umar Yousaf, Raja, Osama, Ishtiaq, Asmara, Malik, Tejhmal, Rehman, Muhammad Umar, Wahab
Publikováno v:
Indian Journal of Endocrinology and Metabolism. 25:456
Our objective was to ascertain the efficacy and safety of once weekly Dulaglutide among patients with Type 2 diabetes of Pakistani origin.This prospective cohort study was conducted at the Endocrinology Clinics of Shifa International Hospital, Islama
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b1c87c6ef76e74e079c42fbf7e65612
https://doi.org/10.4103/ijem.ijem_402_21
https://doi.org/10.4103/ijem.ijem_402_21
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.